newsfilter
← Latest News
GlobeNewswire·

TCR² Therapeutics to Present at the SVB Leerink Global Healthcare Conference

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- TCR2 Therapeutics Inc. (NASDAQ:TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for cancer patients suffering from solid tumors, today announced that management w